ACTN2 mutations cause “Multiple structured Core Disease” (MsCD)
- 432 Downloads
The identification of genes implicated in myopathies is essential for diagnosis and for revealing novel therapeutic targets. Here we characterize a novel subclass of congenital myopathy at the morphological, molecular, and functional level. Through exome sequencing, we identified de novo ACTN2 mutations, a missense and a deletion, in two unrelated patients presenting with progressive early-onset muscle weakness and respiratory involvement. Morphological and ultrastructural analyses of muscle biopsies revealed a distinctive pattern with the presence of muscle fibers containing small structured cores and jagged Z-lines. Deeper analysis of the missense mutation revealed mutant alpha-actinin-2 properly localized to the Z-line in differentiating myotubes and its level was not altered in muscle biopsy. Modelling of the disease in zebrafish and mice by exogenous expression of mutated alpha-actinin-2 recapitulated the abnormal muscle function and structure seen in the patients. Motor deficits were noted in zebrafish, and muscle force was impaired in isolated muscles from AAV-transduced mice. In both models, sarcomeric disorganization was evident, while expression of wild-type alpha-actinin-2 did not result in muscle anomalies. The murine muscles injected with mutant ACTN2 displayed cores and Z-line defects. Dominant ACTN2 mutations were previously associated with cardiomyopathies, and our data demonstrate that specific mutations in the well-known Z-line regulator alpha-actinin-2 can cause a skeletal muscle disorder.
KeywordsACTN2 Alpha-actinin-2 Congenital myopathy Core myopathy Z-line Nemaline myopathy
We thank the families for their participation in the study. We also thank Valentina Lionello, Loïc Talide, Suzie Buono, Coralie Spiegelhalter, Bruno Weber and Pascale Koebel for technical assistance, Jahannaz Dastgir, Katherine Meilleur, Neal Busis, Lauren Elman, Xilma Ortiz-Gonzalez, and Henry Wessel for their help with patient care, and Susana Quijano-Roy, Christopher Mendoza and Gilberto Averion for their help in clinic. We also would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.
NBR, CB, JB, JL conceived and designed the study. XL, CAG, SD, MMM, SN, ARF, CL, KRC, LM, JFD performed the experiments. XL, NBR, EM, SD, SN, ARF, RS, RYC, CB, VAG, MF analyzed the data. XL, NBR, MF, JB, JL wrote the manuscript with input from the other coauthors.
This study was supported by the grant ANR-10-LABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d’Avenir ANR-10-IDEX-0002-02. This work was funded by the Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), University of Strasbourg, GIS IBiSA maladies rares, the France Génomique National infrastructure funded as part of the Investissements d’Avenir program managed by the Agence Nationale pour la Recherche (ANR-10-INBS-09) and by Fondation Maladies Rares within the frame of the “Myocapture” sequencing project, the Fondation pour la Recherche Médicale, and the Association Française contre les Myopathies. The work performed at the NIH was supported by intramural funds from the NIH National Institute of Neurological Disorders and Stroke. Sequencing analysis was provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics and was funded by the National Human Genome Research Institute, the National Eye Institute and the National Heart, Lung and Blood Institute grant UM1 HG008900 to Daniel MacArthur and Heidi Rehm.
Compliance with ethical standards
Conflict of interest
None of the authors reports conflicts of interest.
- 3.Bennett AH, O’Donohue MF, Gundry SR, Chan AT, Widrick J, Draper I et al (2018) RNA helicase, DDX27 regulates skeletal muscle growth and regeneration by modulation of translational processes. PLoS Genet 14:e1007226. https://doi.org/10.1371/journal.pgen.1007226 CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Carlier R (2014) MNM et IRM musculaire/corps entier: apport au diagnostic et au suivi. In: AFM-Téléthon, Société Française de Myologie SFM (eds) Les Cahiers de Myologie, pp 22-32Google Scholar
- 7.Cowling BS, Toussaint A, Amoasii L, Koebel P, Ferry A, Davignon L et al (2011) Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness. Am J Pathol 178:2224–2235. https://doi.org/10.1016/j.ajpath.2011.01.054 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Fardeau M (1982) Congenital Myopathies. In: Mastaglia F, Walton J (eds) Skeletal muscle pathology, 2nd edn. Churchill Livingstone, Edinburgh, pp 237–281Google Scholar
- 18.Girolami F, Iascone M, Tomberli B, Bardi S, Benelli M, Marseglia G et al (2014) Novel alpha-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study. Circ Cardiovasc Genet 7:741–750. https://doi.org/10.1161/CIRCGENETICS.113.000486 CrossRefPubMedGoogle Scholar
- 19.Gupta V, Discenza M, Guyon JR, Kunkel LM, Beggs AH (2012) alpha-Actinin-2 deficiency results in sarcomeric defects in zebrafish that cannot be rescued by alpha-actinin-3 revealing functional differences between sarcomeric isoforms. FASEB J 26:1892–1908. https://doi.org/10.1096/fj.11-194548 CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Haywood NJ, Wolny M, Rogers B, Trinh CH, Shuping Y, Edwards TA et al (2016) Hypertrophic cardiomyopathy mutations in the calponin-homology domain of ACTN2 affect actin binding and cardiomyocyte Z-disc incorporation. Biochem J 473:2485–2493. https://doi.org/10.1042/BCJ20160421 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Landon D (1982) Skeletal muscle—normal morphology, development and innervation. In: Walton J, Mastaglia F (eds) Skeletal muscle pathology. Churchill Livingstone, Edinburgh, pp 1–87Google Scholar
- 28.Lu L, Timofeyev V, Li N, Rafizadeh S, Singapuri A, Harris TR et al (2009) Alpha-actinin2 cytoskeletal protein is required for the functional membrane localization of a Ca2+-activated K+ channel (SK2 channel). Proc Natl Acad Sci USA 106:18402–18407. https://doi.org/10.1073/pnas.0908207106 CrossRefPubMedGoogle Scholar
- 29.MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N et al (2008) An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet 17:1076–1086. https://doi.org/10.1093/hmg/ddm380 CrossRefPubMedGoogle Scholar
- 39.Robison AJ, Bass MA, Jiao Y, MacMillan LB, Carmody LC, Bartlett RK et al (2005) Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2. J Biol Chem 280:35329–35336. https://doi.org/10.1074/jbc.M502191200 CrossRefPubMedGoogle Scholar
- 40.Romero NB, Clarke NF (2013) Congenital myopathies. Handb Clin Neurol 113:1321–1336. https://doi.org/10.1016/B978-0-444-59565-2.00004-6 CrossRefPubMedGoogle Scholar
- 45.Westerfield M (2007) The Zebrafish Book: a guide for the laboratory use of Zebrafish (Danio Rerio), CityGoogle Scholar